Wirth K J, Knobloch K
DG Cardiovascular Diseases, Aventis Pharma, Industriepark Höchst, Frankfurt am Main, Germany.
Naunyn Schmiedebergs Arch Pharmacol. 2001 Feb;363(2):166-74. doi: 10.1007/s002100000328.
Antiarrhythmic drugs have been shown to prolong right atrial refractoriness while data on the left atrium are not available. In pigs we have observed shorter effective refractory periods (ERP) of the left compared with the right atrium associated with a much higher left atrial vulnerability for tachyarrhythmias. Since this could suggest a different distribution of repolarizing ion channels in left and right atrium, we investigated whether antiarrhythmic drugs blocking different ion channels have a differential effect on left and right atrial ERP and left atrial vulnerability.
In pentobarbital-anesthetized pigs (n=40) we measured and compared ERPs in both atria before and after different drugs with the S1-S2 extrastimulus method at three basic cycle lengths (BCL) and assessed the inducibility of atrial fibrillation/flutter (AF/AFL) by the premature S2 stimulus.
At the three BCL tested (240/300/400 ms) baseline ERPs were shorter in left vs. right atrium (112+/-2/124+/-2/129+/-2 ms vs. 147+/-2/163+/-2/167+/-2 ms, P<0.001). Mostly non-sustained AF/AFL induced by the S2 extrastimulus was very frequent in the left (68%) and nearly absent in the right atrium (3%). Only amiodarone, 5 mg/kg i.v., which showed a balanced increase of left and right atrial ERP (29+/-5/33+/-4/35+/-3% vs. 30+/-5/35+/-5/42+/-7%), decreased the inducibility of AF/AFL significantly (-72%, P<0.01). Dofetilide, 10 microg/kg i.v., had a stronger effect on right than left atrial ERP (36+/-4/39+/-5/46+/-10% vs. 23+/-2/22+/-7/22+/-5%, P<0.05), while flecainide, 1 mg/kg i.v., prolonged left more than right atrial ERP (58+/-15/36+/-7/40+/-7% vs. 26+/-5/24+/-5/21+/-4%, P<0.05) similar to 1 mg/ kg of propafenone (46+/-5/45+/-7/32+/-10% vs. 17+/-4/21+/-5/ 25+/-8%, P<0.05).
The shorter refractoriness of the left compared with the right atrium observed in pigs was associated with a high left atrial vulnerability for tachyarrhythmias, which was reduced only by amiodarone showing a balanced increase of left and right atrial ERP. Dofetilide was stronger on right atrial ERP, flecainide and propafenone on left atrial ERP. These differences suggest a differential distribution of repolarizing ion channels between left and right atrium with possible relevance for the antiarrhythmic efficacy of drugs.
抗心律失常药物已被证明可延长右心房不应期,而关于左心房的数据尚不可得。在猪身上,我们观察到与右心房相比,左心房的有效不应期(ERP)更短,且左心房对快速性心律失常的易感性更高。由于这可能提示左、右心房复极化离子通道的分布不同,我们研究了阻断不同离子通道的抗心律失常药物对左、右心房ERP及左心房易感性是否有不同影响。
在戊巴比妥麻醉的猪(n = 40)中,我们采用S1 - S2额外刺激法,在三个基本周期长度(BCL)下测量并比较不同药物给药前后左、右心房的ERP,并通过提前给予S2刺激评估心房颤动/扑动(AF/AFL)的诱发情况。
在测试的三个BCL(240/300/400毫秒)下,左心房的基线ERP短于右心房(分别为112±2/124±2/129±2毫秒与147±2/163±2/167±2毫秒,P<0.001)。由S2额外刺激诱发的大多为非持续性AF/AFL在左心房很常见(68%),而在右心房几乎不存在(3%)。仅静脉注射5毫克/千克的胺碘酮可使左、右心房ERP均衡增加(分别为29±5/33±4/35±3%与30±5/35±5/42±7%),并显著降低AF/AFL的诱发率(-72%,P<0.01)。静脉注射10微克/千克的多非利特对右心房ERP的作用强于左心房(分别为36±4/39±5/46±10%与23±2/22±7/22±5%,P<0.05),而静脉注射1毫克/千克的氟卡尼使左心房ERP延长的幅度大于右心房(分别为58±15/36±7/40±7%与26±5/24±5/21±4%,P<0.05),与静脉注射1毫克/千克的普罗帕酮情况相似(分别为46±5/45±7/32±10%与17±4/21±5/25±8%,P<0.05)。
在猪身上观察到的左心房与右心房相比不应期较短的情况,与左心房对快速性心律失常的高易感性相关,仅胺碘酮可降低这种易感性,其使左、右心房ERP均衡增加。多非利特对右心房ERP作用更强,氟卡尼和普罗帕酮对左心房ERP作用更强。这些差异提示左、右心房复极化离子通道分布不同,这可能与药物的抗心律失常疗效相关。